(4R)-4-[(3R)-3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxybutyl]-3,5,5-trimethylcyclohex-2-en-1-one

Details

Top
Internal ID f4e8e36e-3536-4589-acce-0992683e5f85
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Fatty acyl glycosides > Fatty acyl glycosides of mono- and disaccharides
IUPAC Name (4R)-4-[(3R)-3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxybutyl]-3,5,5-trimethylcyclohex-2-en-1-one
SMILES (Canonical) CC1=CC(=O)CC(C1CCC(C)OC2C(C(C(C(O2)COC3C(C(C(O3)CO)O)O)O)O)O)(C)C
SMILES (Isomeric) CC1=CC(=O)CC([C@H]1CC[C@@H](C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@@H](O3)CO)O)O)O)O)O)(C)C
InChI InChI=1S/C24H40O11/c1-11-7-13(26)8-24(3,4)14(11)6-5-12(2)33-23-21(31)19(29)18(28)16(35-23)10-32-22-20(30)17(27)15(9-25)34-22/h7,12,14-23,25,27-31H,5-6,8-10H2,1-4H3/t12-,14+,15+,16-,17+,18-,19+,20-,21-,22-,23-/m1/s1
InChI Key WMOJOCZNFPTCBX-XKEMEYHGSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C24H40O11
Molecular Weight 504.60 g/mol
Exact Mass 504.25706209 g/mol
Topological Polar Surface Area (TPSA) 175.00 Ų
XlogP -1.20
Atomic LogP (AlogP) -1.00
H-Bond Acceptor 11
H-Bond Donor 6
Rotatable Bonds 9

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (4R)-4-[(3R)-3-[(2R,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxybutyl]-3,5,5-trimethylcyclohex-2-en-1-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.5587 55.87%
Caco-2 - 0.8490 84.90%
Blood Brain Barrier - 0.6000 60.00%
Human oral bioavailability - 0.7857 78.57%
Subcellular localzation Mitochondria 0.8873 88.73%
OATP2B1 inhibitior - 0.8605 86.05%
OATP1B1 inhibitior + 0.8702 87.02%
OATP1B3 inhibitior + 0.8369 83.69%
MATE1 inhibitior - 0.9812 98.12%
OCT2 inhibitior - 0.6500 65.00%
BSEP inhibitior - 0.6982 69.82%
P-glycoprotein inhibitior - 0.6357 63.57%
P-glycoprotein substrate - 0.6624 66.24%
CYP3A4 substrate + 0.6527 65.27%
CYP2C9 substrate - 0.7958 79.58%
CYP2D6 substrate - 0.8855 88.55%
CYP3A4 inhibition - 0.9390 93.90%
CYP2C9 inhibition - 0.8229 82.29%
CYP2C19 inhibition - 0.8800 88.00%
CYP2D6 inhibition - 0.9243 92.43%
CYP1A2 inhibition - 0.8922 89.22%
CYP2C8 inhibition - 0.8019 80.19%
CYP inhibitory promiscuity - 0.8719 87.19%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.6249 62.49%
Eye corrosion - 0.9897 98.97%
Eye irritation - 0.9623 96.23%
Skin irritation - 0.6507 65.07%
Skin corrosion - 0.9501 95.01%
Ames mutagenesis - 0.6300 63.00%
Human Ether-a-go-go-Related Gene inhibition + 0.6800 68.00%
Micronuclear - 0.8700 87.00%
Hepatotoxicity - 0.7782 77.82%
skin sensitisation - 0.8868 88.68%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity + 0.6889 68.89%
Mitochondrial toxicity + 0.5375 53.75%
Nephrotoxicity + 0.5870 58.70%
Acute Oral Toxicity (c) III 0.5797 57.97%
Estrogen receptor binding + 0.5811 58.11%
Androgen receptor binding - 0.5922 59.22%
Thyroid receptor binding + 0.5650 56.50%
Glucocorticoid receptor binding - 0.4845 48.45%
Aromatase binding + 0.6472 64.72%
PPAR gamma + 0.5355 53.55%
Honey bee toxicity - 0.8090 80.90%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.7550 75.50%
Fish aquatic toxicity + 0.9611 96.11%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.69% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 96.37% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.92% 96.09%
CHEMBL2581 P07339 Cathepsin D 94.73% 98.95%
CHEMBL220 P22303 Acetylcholinesterase 93.85% 94.45%
CHEMBL3137262 O60341 LSD1/CoREST complex 91.44% 97.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 89.30% 94.45%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 88.93% 85.14%
CHEMBL3401 O75469 Pregnane X receptor 87.90% 94.73%
CHEMBL1293255 P15428 15-hydroxyprostaglandin dehydrogenase [NAD+] 87.77% 83.57%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 85.88% 95.56%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 85.02% 96.47%
CHEMBL1937 Q92769 Histone deacetylase 2 84.59% 94.75%
CHEMBL218 P21554 Cannabinoid CB1 receptor 84.55% 96.61%
CHEMBL1994 P08235 Mineralocorticoid receptor 83.99% 100.00%
CHEMBL3880 P07900 Heat shock protein HSP 90-alpha 82.95% 96.21%
CHEMBL1806 P11388 DNA topoisomerase II alpha 82.14% 89.00%
CHEMBL2996 Q05655 Protein kinase C delta 81.80% 97.79%
CHEMBL1871 P10275 Androgen Receptor 81.47% 96.43%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 81.05% 96.00%

Cross-Links

Top
PubChem 101450244
NPASS NPC279886
LOTUS LTS0106156
wikiData Q105308716